@NephRodby

http://twitter.com/NephRodby

@ssfarouk @ASNKidney @suresh_varsh94 @AbhinayaS15 @MadhusudanV92 @Doug_Rud @ISMMSKidney But did you get the question I submitted to the #KidneyWk FIT Bowl correct? The answer was 5-oxoproline or pyroglutamic acid.

— Roger Rodby (@NephRodby) Dec 1, 2023

https://twitter.com/NephRodby/status/1730441765843309008

@ssfarouk

http://twitter.com/ssfarouk

.@ASNKidney 2023 FIT Bowl Champions with their 🏆🥇🥇🥇 Congratulations @suresh_varsh94 @AbhinayaS15 @MadhusudanV92 @Doug_Rud @ISMMSKidney #Nephrology #KidneyWk https://bit.ly/3uMPyDZ

— Samira Farouk, MD, MSCR (@ssfarouk) Dec 1, 2023

https://twitter.com/ssfarouk/status/1730401604556181659

@Acute_Baxter_US

http://twitter.com/Acute_Baxter_US

Couldn’t make it to #KidneyWk ? No worries! We’d love to talk to you about the difference our TOTAL KIDNEY CARE SUPPORT could make to your practice! Let’s connect! 👉 https://bit.ly/3N6kB4f https://bit.ly/3SYe3bA

— Acute Therapies at Baxter - U.S. (@Acute_Baxter_US) Nov 30, 2023

https://twitter.com/Acute_Baxter_US/status/1730286829050458398

@Nephronline

http://twitter.com/Nephronline

🇦🇺 #Australia had the highest percentage of patients who chose home #dialysis, according to research from #KidneyWk. https://bit.ly/3Rn7Qoi

— Nephrology News & Issues (@Nephronline) Nov 30, 2023

https://twitter.com/Nephronline/status/1730270732309983243

@hswapnil

http://twitter.com/hswapnil

@poyanmehr @GrahamAbra @kidney_boy @HumphreysLab <my version of Tom Friedman talking to a cab driver> Speaking to a few US based fellows/younger nephrons at #KidneyWk - money seems to be the big factor (rheum/endo notwithstanding - perhaps its money + lifestyle: lifestyle hasn't changed in neph over the years, but money has)

— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Nov 30, 2023

https://twitter.com/hswapnil/status/1730232650399416691

@ardelyx

http://twitter.com/ardelyx

#TBT to an incredible #ASN #KidneyWk. Thanks to everyone who stopped by our booth, checked out our posters, attended our Exhibitor Spotlight and connected with our team. See you next year! #ArdelyxProud https://bit.ly/3N2ZJL9

— Ardelyx (@ardelyx) Nov 30, 2023

https://twitter.com/ardelyx/status/1730210228132602191

@NephJC

http://twitter.com/NephJC

Here is the live recorded @freelyfiltered episode, where the crew discussed about DUPLEX trial @rheault_m after opening #KidneyWK LBCT, didn’t considered herself too cool to come, pop up on the scen, then party with #NephJC people https://bit.ly/47yukIM

— Nephrology Journal Club (@NephJC) Nov 29, 2023

https://twitter.com/NephJC/status/1729899016832577849

@GlomCon

http://twitter.com/GlomCon

#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/3RnLYcB https://bit.ly/3uCXVCe https://bit.ly/47Srr5h

— GlomCon (@GlomCon) Nov 29, 2023

https://twitter.com/GlomCon/status/1729893163542941705

@GlomCon

http://twitter.com/GlomCon

#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/3RnLYcB https://bit.ly/47Srr5h

— GlomCon (@GlomCon) Nov 29, 2023

https://twitter.com/GlomCon/status/1729892863822229701

@NephJC

http://twitter.com/NephJC

Here is the live recorded @freelyfiltered episode, where the crew discussed about DUPLEX trial @rheault_m after opening #KidneyWK LBCT, didn’t consider herself too cool to come, pop up on the scene, then party with #NephJC people https://bit.ly/3SXbUgh

— Nephrology Journal Club (@NephJC) Nov 29, 2023

https://twitter.com/NephJC/status/1729695173485985849